Cassava Sciences, Inc. $36.91

NCM - Chart Updated: 3 hours ago
Your information:

    • Hello World! bearish Reply


    • Kayla bullish Reply

      What is going on with SAVA it is trending up

    • stockmaster neutral Reply

      Share are trading lower today after the company reported biomarker data from an open-label study of simufilam – their investigational drug for the treatment of Alzheimer’s disease. Not sure why this would move it down… but I believe the stock has traded lower today due to unusual options activity.

      Is this true?

    • Start your discussions now!